Real-Life Treatment Paradigms Show Adalimumab Is Cost-Effective for the Management of Ulcerative Colitis

Background. Adalimumab is effective for the maintenance of remission in patients with moderate-to-severe ulcerative colitis (UC). Currently, biologic therapies are used in cases where patients fail conventional medical therapies. If biologic therapies are not available, patients often choose to rema...

Descripción completa

Detalles Bibliográficos
Autores principales: Beilman, Candace L., Thanh, Nguyen Xuan, Ung, Victoria, Ma, Christopher, Wong, Karen, Kroeker, Karen I., Lee, Thomas, Wang, Haili, Ohinmaa, Arto, Jacobs, Phil, Halloran, Brendan P., Fedorak, Richard N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5065999/
https://www.ncbi.nlm.nih.gov/pubmed/27781203
http://dx.doi.org/10.1155/2016/5315798

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5065999/
https://www.ncbi.nlm.nih.gov/pubmed/27781203
http://dx.doi.org/10.1155/2016/5315798

Ejemplares similares